Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States. (Record no. 28971747)

MARC details
000 -LEADER
fixed length control field 02216 a2200661 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518003901.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201908s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1941-3297
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1161/CIRCHEARTFAILURE.118.005400
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name DeVore, Adam D
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190813
245 00 - TITLE STATEMENT
Title Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Circulation. Heart failure
Date of publication, distribution, etc. 09 2018
300 ## - PHYSICAL DESCRIPTION
Extent e005400 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ambulatory Care
General subdivision trends
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aminobutyrates
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Angiotensin II Type 1 Receptor Blockers
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biphenyl Compounds
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Decision-Making
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Combinations
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Guideline Adherence
General subdivision trends
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heart Failure
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neprilysin
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Patient Selection
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Patients
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Practice Guidelines as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Practice Patterns, Physicians'
General subdivision standards
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protease Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Registries
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Specialization
General subdivision trends
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tetrazoles
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Time Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States
General subdivision epidemiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Valsartan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hill, C Larry
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thomas, Laine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sharma, Puza P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Albert, Nancy M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Butler, Javed
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Patterson, J Herbert
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Spertus, John A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Williams, Fredonia B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Duffy, Carol I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McCague, Kevin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hernandez, Adrian F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fonarow, Gregg C
773 0# - HOST ITEM ENTRY
Title Circulation. Heart failure
Related parts vol. 11
-- no. 9
-- p. e005400
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1161/CIRCHEARTFAILURE.118.005400">https://doi.org/10.1161/CIRCHEARTFAILURE.118.005400</a>
Public note Available from publisher's website

No items available.